FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE

Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Data on the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: O. D. Ostroumova, I. I. Kopchenov
Médium: Artigo
Jazyk:Inglês
Vydáno: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Edice:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Témata:
arterial hypertension
combined therapy
fixed combinations of antihypertensive drugs
ace inhibitors
calcium antagonists
enalapril, lercanidipine
On-line přístup:https://www.rpcardio.com/jour/article/view/284
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky